16 results on '"Stammen, Francis"'
Search Results
2. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug
3. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
4. Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
5. The evolution of the CTO-PCI landscape in Belgium and Luxembourg: a four-year appraisal.
6. Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study.
7. A quality project for radiation reduction in the cath lab.
8. Assessing the landscape of percutaneous coronary chronic total occlusion treatment in Belgium and Luxembourg: the Belgian Working Group on Chronic Total Occlusions (BWGCTO) registry.
9. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
10. Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease.
11. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry.
12. Long-term follow-up after percutaneous coronary intervention with polytetrafluoroethylene-covered Symbiot™ stents compared to bare metal stents, with and without FilterWire™ embolic protection, in diseased saphenous vein grafts.
13. Outcome following coronary balloon angioplasty in young adults aged 35 years or less.
14. Use of an autoperfusion catheter in the treatment of acute refractory vessel closure after coronary balloon angioplasty: immediate and six month follow up results*.
15. Immediate and 6-month follow-up results of coronary angioplasty for restenosis: Analysis of factors predicting recurrent clinical restenosis
16. CLINICAL OUTCOMES TO 4 YEARS IN PATIENTS IMPLANTED WITH BIOABSORBABLE POLYMER SYNERGY VERSUS PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: THE EVOLVE II RANDOMIZED TRIAL.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.